<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04864301</url>
  </required_header>
  <id_info>
    <org_study_id>TSMT</org_study_id>
    <nct_id>NCT04864301</nct_id>
  </id_info>
  <brief_title>Tumescent Stretching Measurement Technique</brief_title>
  <acronym>TSMT</acronym>
  <official_title>Tumescent Stretching Measurment Technique: A New Technique for Intraoperartive Measurement of Inflatable Penile Implant Size</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introducing and evaluating the accuracy of a novel method for estimating inflatable penile&#xD;
      prosthesis cylinders length by stretching the tumesncent penis intraoperatively instead of&#xD;
      taking proximla and distal measurement to the corporotomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:&#xD;
&#xD;
      Introducing and evaluating the accuracy of a novel method for estimating inflatable penile&#xD;
      prosthesis cylinders length.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      24 patients undergoing a Coloplast Titan Â® Touch implantation procedure will berandomly&#xD;
      divided into two groups.&#xD;
&#xD;
      The &quot;Tumescent Stretching Measurement Technique&quot; (TSMT) group (N=12) will be administered an&#xD;
      intracorporal injection (ICI) of 20 microgram Alprostadil. Hegar 7 dilator will be introduced&#xD;
      through the corporotomy until reaching a bone stopping point. The tumescent penis will be&#xD;
      stretched maximally, and the proximally inserted dilator measured externally to the coronal&#xD;
      sulcus.&#xD;
&#xD;
      The control group (N=12) will receive no intraoperative ICI. Following maximal corporal&#xD;
      dilatation, cylinder length will be estimated by adding up the internally measured distal and&#xD;
      proximal corpora to the length of the corporotomy.&#xD;
&#xD;
      Implants are deemed correctly sized when cylinders reached the proximal third of the glans&#xD;
      with no buckling of cylinders or floppy glans.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of penile implant insertions and re-insertions needed to arrive to adequate penile implant size</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Number of penile implant insertions and re-insertions needed to arrive to adequate penile implant size</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>To Try to Eliminate Frequencies of Insertions in Order to Arrive to Adequate Size of Implanted Penile Prosthesis</condition>
  <arm_group>
    <arm_group_label>Tumescent Stretching Measurement Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The &quot;Tumescent Stretching Measurement Technique&quot; (TSMT) group (N=12) will be administered an intracorporal injection (ICI) of 20 microgram Alprostadil. Hegar 7 dilator will be introduced through the corporotomy until reaching a bone stopping point. The tumescent penis will stretched maximally, and the proximally inserted dilator measured externally to the coronal sulcus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Measurement technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group (N=12) will receive no intraoperative ICI. Following maximal corporal dilatation, cylinder length will be estimated conventionally by adding up the internally measured distal and proximal corpora to the length of the corporotomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tumescent Stretching Measurement Technique</intervention_name>
    <description>The &quot;Tumescent Stretching Measurement Technique&quot; (TSMT) group (N=12) will be administered an intracorporal injection (ICI) of 20 microgram Alprostadil. Hegar 7 dilator will be introduced through the corporotomy until reaching a bone stopping point. The tumescent penis will stretched maximally, and the proximally inserted dilator measured externally to the coronal sulcus.</description>
    <arm_group_label>Conventional Measurement technique</arm_group_label>
    <arm_group_label>Tumescent Stretching Measurement Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Males needing Penile implant surgery, not responding to oral pharmacological drugs for ttt&#xD;
        of ED -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Previouys penile surgery Previous implanted penile prosthesis&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Penile Implants for Males</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 24, 2021</study_first_submitted>
  <study_first_submitted_qc>April 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 24, 2021</last_update_submitted>
  <last_update_submitted_qc>April 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Adham ZAAZAA</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>penile implant, iflatable penile implant, re-insertion, measurement</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

